Cargando…

Corrigendum: IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth

Detalles Bibliográficos
Autores principales:	Yang, Rui, Yao, Lan, Shen, Ling, Sha, Wei, Modlin, Robert L., Shen, Hongbo, Chen, Zheng W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677117/ https://www.ncbi.nlm.nih.gov/pubmed/31404161 http://dx.doi.org/10.3389/fimmu.2019.01742

Ejemplares similares

IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth
por: Yang, Rui, et al.
Publicado: (2019)

Adjunctive Zoledronate + IL-2 administrations enhance anti-tuberculosis Vγ2Vδ2 T-effector populations, and improve treatment outcome of multidrug-resistant tuberculosis(1)
por: Shen, Hongbo, et al.
Publicado: (2022)

Cytokine-mediated activation of human ex vivo-expanded Vγ9Vδ2 T cells
por: Domae, Eisuke, et al.
Publicado: (2017)

Immunization of Vγ2Vδ2 T cells programs sustained effector memory responses that control tuberculosis in nonhuman primates
por: Shen, Ling, et al.
Publicado: (2019)

Characteristics of peripheral Vγ2Vδ2 T cells in interferon-γ release assay negative pulmonary tuberculosis patients
por: Yan, Liping, et al.
Publicado: (2018)

Effector Vγ9Vδ2 T cell response to congenital Toxoplasma gondii infection
por: Ma, Ling, et al.
Publicado: (2021)

Generation of effector Vγ9Vδ2 T cells and evaluation of their response to phosphoantigen-loaded cells
por: Hsiao, Chia-Hung Christine, et al.
Publicado: (2022)

Phenotypic and functional characterization of pharmacologically expanded Vγ9Vδ2 T cells in pigtail macaques
por: Barber-Axthelm, Isaac M., et al.
Publicado: (2023)

Phosphoantigen/IL2 Expansion and Differentiation of Vγ2Vδ2 T Cells Increase Resistance to Tuberculosis in Nonhuman Primates
por: Chen, Crystal Y., et al.
Publicado: (2013)

Bispecific Antibody PD-L1 x CD3 Boosts the Anti-Tumor Potency of the Expanded Vγ2Vδ2 T Cells
por: Yang, Rui, et al.
Publicado: (2021)

Beneficial Effect of Antibiotics and Microbial Metabolites on Expanded Vδ2Vγ9 T Cells in Hepatocellular Carcinoma Immunotherapy
por: Han, Jiajia, et al.
Publicado: (2020)

Preferential Th1 Cytokine Profile of Phosphoantigen-Stimulated Human Vγ9Vδ2 T Cells
por: Dunne, Margaret R., et al.
Publicado: (2010)

E. coli promotes human Vγ9Vδ2 T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner
por: Barisa, M., et al.
Publicado: (2017)

Co-Expansion of Cytokine-Induced Killer Cells and Vγ9Vδ2 T Cells for CAR T-Cell Therapy
por: Du, Shou-Hui, et al.
Publicado: (2016)

Nanocages engineered from Bacillus Calmette-Guerin facilitate protective Vγ2Vδ2 T cell immunity against Mycobacterium tuberculosis infection
por: Pi, Jiang, et al.
Publicado: (2022)

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells
por: Gu, Siyi, et al.
Publicado: (2015)

Role of Vγ9vδ2 T lymphocytes in infectious diseases
por: Gay, Laetitia, et al.
Publicado: (2022)

Mapping of γ/δ T cells reveals Vδ2+ T cells resistance to senescence
por: Xu, Weili, et al.
Publicado: (2018)

Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity
por: Accardo-Palumbo, Antonina, et al.
Publicado: (2010)

Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth
por: Mao, Tsui Lien, et al.
Publicado: (2019)

Preferential Infiltration of Unique Vγ9Jγ2-Vδ2 T Cells Into Glioblastoma Multiforme
por: Lee, Mijeong, et al.
Publicado: (2019)

Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
por: Hoeres, Timm, et al.
Publicado: (2018)

Development and Selection of the Human Vγ9Vδ2(+) T-Cell Repertoire
por: Willcox, Carrie R., et al.
Publicado: (2018)

The PPARα pathway in Vγ9Vδ2 T cell anergy
por: Poupot, Mary, et al.
Publicado: (2014)

Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapy
por: Ridgley, Laura A., et al.
Publicado: (2023)

Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer
por: Wada, Ikuo, et al.
Publicado: (2014)

A Subset of Protective γ(9)δ(2) T Cells Is Activated by Novel Mycobacterial Glycolipid Components
por: Xia, Mei, et al.
Publicado: (2016)

Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions
por: Cimini, Eleonora, et al.
Publicado: (2015)

Role of Vγ9Vδ2+ γδ T cells in juvenile idiopathic arthritis
por: Gerstein, M, et al.
Publicado: (2008)

BTLA, a key regulator of Vγ9Vδ2 T-cell proliferation
por: Gertner-Dardenne, Julie, et al.
Publicado: (2013)

An Update on the Molecular Basis of Phosphoantigen Recognition by Vγ9Vδ2 T Cells
por: Herrmann, Thomas, et al.
Publicado: (2020)

The human Vδ2(+) T-cell compartment comprises distinct innate-like Vγ9(+) and adaptive Vγ9(-) subsets
por: Davey, Martin S., et al.
Publicado: (2018)

Granzyme A Produced by γ(9)δ(2) T Cells Activates ER Stress Responses and ATP Production, and Protects Against Intracellular Mycobacterial Replication Independent of Enzymatic Activity
por: Rasi, Valerio, et al.
Publicado: (2021)

Human Vγ9Vδ2 T Lymphocytes in the Immune Response to P. falciparum Infection
por: Howard, Jennifer, et al.
Publicado: (2018)

Mistletoe-Extract Drugs Stimulate Anti-Cancer Vγ9Vδ2 T Cells
por: Ma, Ling, et al.
Publicado: (2020)

Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance
por: Nussbaumer, Oliver, et al.
Publicado: (2020)

Generation and application of TGFβ-educated human Vγ9Vδ2 T cells
por: Parente-Pereira, Ana C., et al.
Publicado: (2022)

Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time?
por: Giannotta, Claudia, et al.
Publicado: (2023)

Human Umbilical Cord Mesenchymal Stem Cells Inhibit the Function of Allogeneic Activated Vγ9Vδ2 T Lymphocytes In Vitro
por: Liu, Xiaohuan, et al.
Publicado: (2015)

Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells
por: Yuan, Linjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nb3t20fgdose7j1n7h87o9jgqj